Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Who is the clown who can't read a prepared statement?

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on Jun 19, 2024 8:12pm

214 Views

Post# 36097040

RE:RE:RE:Who is the clown who can't read a prepared statement?

Respectfully, what's wrong is Roger has been trying for 2 years to raise the $5m to become shelf eligible with NO success. Every pp dilutes shareholder value in the meantime. He could easily have issued $5m in debt a long time ago and we would have been able to complete GLP long ago and add real value with other Phase 1b studies lined up. His dismissal of the notion of issuing debt flies in the face of 2 years of pp failures. Otherwise I am glad he will not do a reverse split.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles